Power3 Medical's Impact on Neurodegenerative Diseases

Power3 Medical's study of protein concentrations in blood serum has resulted in a remarkable breakthrough in the diagnosis of Neurodegenerative diseases. This discovery is believed to have direct applicability in the early detection of:

• Alzheimer's Disease
• ALS (Lou Gerig's Disease)
• Parkinson's Disease

For centuries these diseases have plagued the elderly generation and perplexed physicians around the world. All three diseases involve the deterioration of brain cells and the nervous system to the point of disability and death. Current diagnosis methods are predominately symptom-based, therefore unable to detect the disease until irreversible brain damage has already occured.

Power3's diagnostic methods distinguish individually diseased patients from each other, as well as from normal patients and patients with other neurological disorders. Furthermore, and most notably, these methods have the potential to distinguish patients with Alzheimer's, ALS, and Parkinson's diseases before symptoms begin.